Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "continuous renal replacement therapy"

A Comparison between Two Dilute Citrate Solutions (15 vs. 18 m...

Background/Aims: The study aimed to compare the changes in biochemistry occurring in patients undergoing continuous renal replacement therapy (CRRT) using 2 trisodium citrate solutions, Baxter hemofiltration fluid containing 18 mmol/l (C18) and ... Blood Purification, 3 weeks ago
Renal Replacement Therapy Rates Declining in Some Countries General Medicine eJournal, 1 month ago

10 images for continuous renal replacement therapy

MyNewsDesk, 1 week ago
MyNewsDesk, 3 weeks ago
Medagadget.com, 3 months ago
MyNewsDesk, 4 months ago
Low Carbon Economy, 6 months ago
Medagadget.com, 6 months ago
Medagadget.com, 3 months ago
Medagadget.com, 4 months ago
Medical News Today, 2 months ago
First Post.com, 3 months ago

Early Initiation of Renal Replacement Therapy Improves Mortality in Critically Ill Patients with Acute Kidney Injury

C linical question: For critically ill patients with acute kidney injury, does early initiation of renal replacement therapy improve mortality? Bottom line: In this single-center study, early initiation of renal replacement therapy (RRT) in ...
 Hospitalist.org2 weeks ago Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy  Karger.com2 weeks ago Critically Ill Acute Kidney Injury Patients Benefit from Early RRT  Renal & Urology News2 months ago Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit  New England Journal of Medicine2 months ago
[x]  
MyNewsDesk

Market Size of Continuous Renal Replacement Therapy, Forecast Report 2016-2026

Future Market Insights has announced the addition of the Continuous Renal Replacement Therapy Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. This press release was orginally distributed by SBWire ...
 Digital Journal1 week ago Global Continuous Renal Replacement Therapy (CRRT) Market - Expected to Reach $1290 Million by 2022 - Research and Markets  TMC Net1 week ago Continuous Renal Replacement Therapy Market Consumption Forecast, 2016 to 2027  Before It's News2 weeks ago FMI Releases New Report on the Continuous Renal Replacement Therapy Market 2016-2026  MyNewsDesk2 months ago
[x]  

Singer donates 3 more dialysis machines under Thirst ...

Singer Sri Lanka, the country's leading consumer durable retailer, donated three CRRT (Continuous Renal Replacement Therapy) machines worth over Rs. 7.5 million under the Singer Thirst for Life health and wellness sustainability project, making the ...
 Daily Mirror Sri Lanka2 weeks ago Singer donates dialysis machines under Thirst for Life project  Sri Lanka Daily News2 weeks ago

Renal Replacement Therapies Asahi Kasei

Important customer notice Recall Ref: 2016/108 ICN number: 108 Date: 23/06/2016 Product area: Change: Asahi Kasei has appointed a distributor for their renal products As a result of this we are currently undertaking a novation to bring ...
 NHS SupplyChain3 weeks ago

Renal Disease Treatments: Products and Therapies

/PRNewswire/ -- This BCC Research report provides a comprehensive analysis of the renal disease market and its trends from 2016 through 2021. In-depth analysis is provided on predominant treatment of kidney diseases, including pharmaceutical ...
 Bloomberg3 weeks ago
[x]  

Peritoneal Dialysis Policy, Reimbursement, and Prevalence

W hen patients with end-stage renal disease (ESRD) are provided with an informed choice of renal replacement modality, approximately 40% of patients choose peritoneal dialysis (PD). Indeed, there are multiple factors favoring PD, including an ...
 Endovascular Today3 weeks ago Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease  Karger.com1 month ago

Immunicum presents continued improvement in phase I/II survival data for INTUVAX-treated renal cancer patients

Read more ›› By: Nasdaq / GlobenewsWire - 13 Jun 2016 Related companies: Immunomedics, Inc. Lifestyle Intervention Achieves Increased Reduction in A1C After Six Months for African Americans with Type 2 Diabetes NEW ORLEANS, June 12, ...
 USA Life Sciences Database1 month ago Adamas Announces Additional ADS-5102 Data for the Treatment of Levodopa-induced Dyskinesia at the International Congress of Parkinson's Disease and Movement Disorders  International Business Times1 month ago ADAMAS PHARMACEUTICALS : Announces Additional ADS-5102 Data for the Treatment of Levodopa-induced Dyskinesia at the International Congress of Parkinson's Disease and Movement Disorders  4 Traders1 month ago
[x]  

Anthera Provides Clinical Program Updates for Blisibimod and Sollpura®

Positive trends from BRIGHT-SC proof-of-concept study study to continue SOLUTION study with Sollpura completed patient screening ahead of schedule data in 2016 First patients screened in Phase 3 CHABLIS 7.5 study of blisibimod in seropositive ...
 Benzinga.com3 weeks ago Anthera Pharmaceuticals' (ANTH) Craig Thompson on Clinical Updates Call Transcript  Seeking Alpha3 weeks ago
[x]  
PharmaVOICE

Bristol-Myers Squibb and PsiOxus Therapeutics Announce Immuno-Oncology Clinical Collaboration to Evaluate the Combination of Opdivo and Enadenotucirev

Bristol-Myers Squibb and PsiOxus Therapeutics Announce Immuno-Oncology Clinical Collaboration to Evaluate the Combination of Opdivo and Enadenotucirev Bristol-Myers Squibb Company ( NYSE: BMY ) and PsiOxus Therapeutics, Ltd. (PsiOxus) today ...
 Minyanville3 weeks ago Bristol-Myers Squibb's Opdivo (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Advanced Form of Bladder Cancer  Business Wire4 weeks ago Bristol-Myers Squibb to Present New Data Demonstrating Continued Research Expansion and Immuno-Oncology Advancements Across Multiple Blood Cancers at the 21st Congress of the European Hematology Association  Nasdaq1 month ago Long-Term Survival and Improvement in Quality of Life Observed with Opdivo® (nivolumab) in Advanced Renal Cell Carcinoma Patients Based on New Data Presented at the 2016 ASCO Annual Meeting  Minyanville1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less